INS and breast cancer: To evaluate the specific impact of insulin and IGF1 signaling on the subcellular distribution and activation of INSR and IGF1R, MCF7 breast cancer-derived cells with disrupted INSR (INSR-KD) or IGF1R (IGF1R-KD) were employed.